Gilder Gagnon Howe & CO LLC Verrica Pharmaceuticals Inc. Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$7.1 - $11.62 $1.66 Million - $2.72 Million	-234,116 Closed	0 $0
Q1 2019 May 17, 2019	BUY	$7.95 - $14.07 $5,350 - $9,469	673 Added 0.29%	234,116 $2.53 Million
Q4 2018 Feb 14, 2019	BUY	$6.75 - $16.12 $444,615 - $1.06 Million	65,869 Added 39.31%	233,443 $1.9 Million
Q3 2018 Oct 30, 2018	BUY	$13.94 - $19.88 $258,308 - $368,376	18,530 Added 12.43%	167,574 $2.72 Million
Q2 2018 Jul 31, 2018	BUY	$17.5 - $20.34 $2.61 Million - $3.03 Million	149,044 New	149,044 $2.94 Million

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.